Emdifen

艾姆地芬

Report date: 2022/07/15 15:58:53
NME

Base Information

Drug NameEmdifen
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTianjin Chase Sun Pharmaceutical Co LtdChinese Academy Of Medical Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Chase Sun Pharmaceutical Co LtdChinese Academy Of Medical Sciences
Inactive CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A